The Hypolipidemic Natural Product Guggulsterone Is a Promiscuous Steroid Receptor Ligand

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Molecular Pharmacology

• Publication date

  2005-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/MOL.104.007054PMID 15602004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guggulsterone Activates Multiple Nuclear Receptors and Induces CYP3A Gene Expression through the Pregnane X Receptor

  2004influential reference
• Design and synthesis of alpha-aryloxy-alpha-methylhydrocinnamic acids: a novel class of dual peroxisome proliferator-activated receptor alpha/gamma agonists.

  2004cited by this paper
• Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial.

  2003cited by this paper
• Guggulipid and Cholesterol Levels

  2003cited by this paper
• A Natural Product Ligand of the Oxysterol Receptor, Liver X Receptor

  2003cited by this paper
• GUGULIPID: a natural cholesterol-lowering agent.

  2003influential reference
• Guggulipid and cholesterol levels. Authors' reply

  2003cited by this paper
• Nuclear receptors and the control of metabolism.

  2003cited by this paper
• Guggulipid and cholesterol levels.

  2003cited by this paper
• Guggulsterone Is a Farnesoid X Receptor Antagonist in Coactivator Association Assays but Acts to Enhance Transcription of Bile Salt Export Pump*

  2003cited by this paper
• The hypolipidemic natural product guggulsterone acts as an antagonist of the bile acid receptor.

  2002influential reference
• A Natural Product That Lowers Cholesterol As an Antagonist Ligand for FXR

  2002influential reference
• Chemical genomics: Functional analysis of orphan nuclear receptors in the regulation of bile acid metabolism

  2001influential reference
• Design and synthesis of 2-methyl-2-[4-(2-[5-methyl-2-aryloxazol-4-yl]ethoxy)phenoxy]propionic acids: a new class of dual PPARalpha/gamma agonists.

  2001cited by this paper
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

  2000cited by this paper
• Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

  2000cited by this paper
• The Farnesoid X-activated Receptor Mediates Bile Acid Activation of Phospholipid Transfer Protein Gene Expression*

  2000cited by this paper
• Nonsteroidal progesterone receptor ligands with unprecedented receptor selectivity.

  2000cited by this paper
• Identification of a chemical tool for the orphan nuclear receptor FXR.

  2000influential reference
• A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.

  1999cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• A study of effect of guggulsterone on hyperlipidemia of secondary glomerulopathy.

  1996influential reference
• Two Androgen Response Regions Cooperate in Steroid Hormone Regulated Activity of the Prostate-specific Antigen Promoter (*)

  1996cited by this paper
• Environmental estrogens: effects on cholesterol lowering and bone in the ovariectomized rat.

  1996cited by this paper
• Lipid Lowering Activity of Guggulsterone from Commiphora mukul in Hyperlipaemic Rats

  1996cited by this paper
• Hypolipidemic and antioxidant effects of commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia

  1994cited by this paper
• Human androgen receptor binding to the androgen response element of prostate specific antigen.

  1994cited by this paper
• Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5' promoter region of the gene.

  1993cited by this paper
• Transcriptional regulation of prostate kallikrein-like genes by androgen.

  1992cited by this paper
• Clinical trials with gugulipid. A new hypolipidaemic agent.

  1989cited by this paper
• Gum guggul (Commiphora mukul)--the success story of an ancient insight leading to a modern discovery.

  1988cited by this paper
• Gum guggul (Commiphora mukul)--the success story of an ancient insight leading to a modern discovery.

  1988cited by this paper
• Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene.

  1987cited by this paper
• Clinical trial of gugulipid--a new hypolipidemic agent of plant origin in primary hyperlipidemia.

  1986cited by this paper
• Plasma lipoproteins during treatment with cyproterone acetate in men with prostatic carcinoma.

  1980cited by this paper
• The effect of cyproterone acetate on serum lipids in normal men.

  1980cited by this paper
• Methyltrienolone, a specific ligand for cellular androgen receptors.

  1975influential reference
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper
• Experimental studies on the hypocholesterolemic effect of Commiphora mukul. Engl. (Guggul).

  1969cited by this paper

• Discovery of farnesoid X receptor antagonists from Salvia miltiorrhiza based on virtual screening and activity verification.

  2025cites this paper
• FXR-targeted drug discovery: Recent advances and therapeutic perspectives.

  2025cites this paper
• Farnesoid X receptor-driven metabolic plasticity: Bridging physiological adaptation and malignant transformation in lipid handling (Review)

  2025cites this paper
• Guggulsterone, a Classical Lipid-Lowering Phytosteroidal FXR Antagonist, as a Modulator of Lipid Signaling and Metabolic Reprogramming in Cancer.

  2025cites this paper
• Development of Radioligand Binding Assays for REV-ERBα and REV-ERBβ.

  2025cites this paper
• Natural Products Targeting the Androgen Receptor Signaling Pathway: Therapeutic Potential and Mechanisms

  2025cites this paper
• Recent advances in dietary androgen receptor inhibitors

  2024cites this paper
• Research Progress of Natural Products with the Activity of Anti-nonalcoholic Steatohepatitis.

  2024cites this paper
• Chemical Diversity of Ketosteroids as Potential Therapeutic Agents

  2024cites this paper
• Medicinal properties and health benefits of guggul-Commiphora mukul

  2023cites this paper
• Theonella: A Treasure Trove of Structurally Unique and Biologically Active Sterols

  2023cites this paper
• Vertical sleeve gastrectomy induces enteroendocrine cell differentiation of intestinal stem cells through bile acid signaling

  2022cites this paper
• Diversity and evolution of secretory structures in Sapindales

  2022cites this paper
• Hypolipidemic Activity of Medicinal Plants: An Overview

  2022cites this paper
• Diversity and evolution of secretory structures in Sapindales

  2022cites this paper
• Z-guggulsterone induces PD-L1 upregulation partly mediated by FXR, Akt and Erk1/2 signaling pathways in non-small cell lung cancer.

  2021cites this paper
• Secoiridoids from Dogwood (Cornus officinalis) Potentiate Progesterone Signaling.

  2021cites this paper
• Commiphora wightii (Arn.) Bhandari/C. mukul (Hook. ex Stocks) Engl. (Burseraceae)

  2020cites this paper
• Therapeutic Effect of Guggulsterone in Primary Cultured Orbital Fibroblasts Obtained From Patients with Graves’ Orbitopathy

  2020cites this paper
• Virucidal Effect of Guggulsterone Isolated from Commiphora gileadensis

  2019cites this paper
• Unsworth, Amanda J and Flora, Gagan D and Gibbins, Jonathan M (2018)Non-genomic effects of nuclear receptors: insights from the anucleate

  2019cites this paper
• Strategies to target bioactive molecules to subcellular compartments. Focus on natural compounds.

  2019cites this paper
• Dissecting the allosteric FXR modulation: a chemical biology approach using guggulsterone as a chemical tool.

  2019cites this paper
• Chemistry and Pharmacology of GPBAR1 and FXR Selective Agonists, Dual Agonists, and Antagonists.

  2019cites this paper
• Structural Insight into the Binding Mode of FXR and GPBAR1 Modulators.

  2019cites this paper
• The Flavonoid Apigenin Is a Progesterone Receptor Modulator with In Vivo Activity in the Uterus

  2018cites this paper
• Non-genomic effects of nuclear receptors: insights from the anucleate platelet

  2018cites this paper
• Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR.

  2018cites this paper
• Estrogen and Thyroid Hormone Receptor Activation by Medicinal Plants from Bahia, Brazil

  2018cites this paper
• Progress and challenges of selective Farnesoid X Receptor modulation.

  2018cites this paper
• Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases

  2018cites this paper
• Irilone from Red Clover ( Trifolium pratense) Potentiates Progesterone Signaling.

  2018cites this paper
• ANTIHYPERLIPIDEMIC ACTIVITY OF COMMIPHORA MUKUL AGAINST ATHEROGENIC DIET-INDUCED HYPERLIPIDEMIA IN EXPERIMENTAL RATS

  2018cites this paper
• Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1

  2017cites this paper
• Cardiovascular Disease Dyslipidemia : Non-Pharmacologic Treatment

  2017cites this paper
• Lipid lowering agents of natural origin: An account of some promising chemotypes.

  2017cites this paper
• Étude bibliographique et analytique des acides β-boswelliques et des guggulstérones, molécules constitutives des résines d’encens et de myrrhe, excipients d’un médicament à usage humain dans un nouveau contexte règlementaire

  2017cites this paper
• Drug Discovery from Mother Nature

  2016cites this paper
• Conformational modulation of the farnesoid X receptor by prenylflavonoids: Insights from hydrogen deuterium exchange mass spectrometry (HDX-MS), fluorescence titration and molecular docking studies.

  2016cites this paper
• The In Vitro and In Vivo Wound Healing Properties of the Chinese Herbal Medicine “Jinchuang Ointment”

  2016cites this paper
• Guggulsterone and Its Role in Chronic Diseases.

  2016cites this paper
• The Halicylindramides, Farnesoid X Receptor Antagonizing Depsipeptides from a Petrosia sp. Marine Sponge Collected in Korea.

  2016cites this paper
• Rôle du récepteur nucléaire FXR dans la régulation de la production de GLP-1 : nouvelle cible thérapeutique dans le traitement du diabète de type 2 ?

  2015cites this paper
• Design, Synthesis, and Biological Evaluation of Novel Nonsteroidal Farnesoid X Receptor (FXR) Antagonists: Molecular Basis of FXR Antagonism

  2015cites this paper
• Part I. The development of non-secosteroidal vitamin D receptor modulators. Part II. The development of a universal GTPase assay

  2015cites this paper
• Randomized, controlled, open-label study of herbal preparation, lekhaneeya mahakashaya ghanavati in dyslipidemia patients

  2015cites this paper
• Steroidal scaffolds as FXR and GPBAR1 ligands: from chemistry to therapeutical application.

  2015cites this paper
• The Effect of Commiphora Mukul of Hydro Alcoholic Extract on Cardiac Enzymes, Lipid Profile and Blood Glucose in Diabetic Male Rats

  2015cites this paper
• Plant based anti-inflammatory secondary metabolites

  2015cites this paper
• Guggulsterone attenuates cerulein-induced acute pancreatitis via inhibition of ERK and JNK activation.

  2015cites this paper
• Guggulsterone for Chemoprevention of Cancer.

  2015cites this paper
• Methods for predicting protein-ligand binding sites.

  2015cites this paper
• Conformational dynamics of human FXR-LBD ligand interactions studied by hydrogen/deuterium exchange mass spectrometry: insights into the antagonism of the hypolipidemic agent Z-guggulsterone.

  2014cites this paper
• IDENTIFICATION OF VDR ANTAGONISTS AMONG NUCLEAR RECEPTOR LIGANDS USING VIRTUAL SCREENING.

  2014cites this paper
• Nouvelles propriétés hépatiques des récepteurs nucléaires FXR et Rev-Erb Alpha

  2014cites this paper
• Prediction of the action of ligands of steroid hormone receptors

  2014cites this paper
• Synthetic FXR agonist GW4064 is a modulator of multiple G protein-coupled receptors.

  2014cites this paper
• Medicinal chemistry and pharmacological effects of Farnesoid X Receptor (FXR) antagonists.

  2014cites this paper
• Quantitative High-Throughput Profiling of Environmental Chemicals and Drugs that Modulate Farnesoid X Receptor

  2014cites this paper
• Targeting Nuclear Receptors with Marine Natural Products

  2014cites this paper
• Discovery and SAR study of hydroxyacetophenone derivatives as potent, non-steroidal farnesoid X receptor (FXR) antagonists.

  2014cites this paper
• Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling.

  2013cites this paper
• Cancer chemopreventive and therapeutic potential of guggulsterone.

  2013cites this paper
• Ethanolic extract of Commiphora mukul gum resin attenuates streptozotocin-induced alterations in carbohydrate and lipid metabolism in rats

  2013cites this paper
• Binding mechanism of the farnesoid X receptor marine antagonist suvanine reveals a strategy to forestall drug modulation on nuclear receptors. Design, synthesis, and biological evaluation of novel ligands.

  2013cites this paper
• Natural Products in Cancer Prevention and Therapy

  2013cites this paper
• Papel del receptor nuclear de ácidos biliares NR1H4 (“farnesoid X receptor”, FXR) en el control de la expresión de genes implicados en el desarrollo de quimiorresistencia. Características funcionales de sus isoformas

  2013cites this paper
• Nuclear receptors in herb–drug interactions

  2013cites this paper
• Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease

  2012cites this paper
• Discovery That Theonellasterol a Marine Sponge Sterol Is a Highly Selective FXR Antagonist That Protects against Liver Injury in Cholestasis

  2012cites this paper
• Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy.

  2012cites this paper
• Farnesoid X receptor: from medicinal chemistry to clinical applications.

  2012cites this paper
• Lipid-Regulating Effect of Traditional Chinese Medicine: Mechanisms of Actions

  2012cites this paper
• Novel stereoselective synthesis and chromatographic evaluation of E-guggulsterone.

  2012cites this paper
• Antiobesity Effects of Conjugated Linoleic Acid: Fact or Fiction?

  2012cites this paper
• Thematic Review Series: New Lipid and Lipoprotein Targets for the Treatment of Cardiometabolic Diseases Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease

  2012cites this paper
• Medicinal chemistry of farnesoid X receptor ligands: from agonists and antagonists to modulators.

  2012cites this paper
• Cycloartane triterpenoids from the stems of Schisandra glaucescens and their bioactivity.

  2012cites this paper
• Natural ligands for nuclear receptors: biology and potential therapeutic applications.

  2012cites this paper
• Pharmacological Properties of Guggulsterones, the Major Active Components of Gum Guggul

  2012cites this paper
• Marine sponge steroids as nuclear receptor ligands.

  2012cites this paper
• Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

  2011cites this paper
• Reversal of Multidrug Resistance by Guggulsterone in Drug-Resistant MCF-7 Cell Lines

  2011cites this paper
• Bile Acid Receptor Agonist GW4064 Regulates PPAR (cid:1) Coactivator-1 (cid:2) Expression Through Estrogen Receptor-Related Receptor (cid:2)

  2011cites this paper
• Tuberatolides, potent FXR antagonists from the Korean marine tunicate Botryllus tuberatus.

  2011cites this paper
• Discovery of sulfated sterols from marine invertebrates as a new class of marine natural antagonists of farnesoid-X-receptor.

  2011cites this paper
• Pharmacophore-based discovery of FXR-agonists. Part II: Identification of bioactive triterpenes from Ganoderma lucidum

  2011cites this paper
• Bile acid receptor agonist GW4064 regulates PPARγ coactivator-1α expression through estrogen receptor-related receptor α.

  2011cites this paper
• Tissue-specific function of farnesoid X receptor in liver and intestine.

  2011cites this paper
• Guggulsterone-Mediated Enhancement of Radiosensitivity in Human Tumor Cell Lines

  2011cites this paper
• Integrative Medicine in the Prevention of Cardiovascular Disease

  2011cites this paper
• Target Profile Prediction: Cross‐Activation of Peroxisome Proliferator‐Activated Receptor (PPAR) and Farnesoid X Receptor (FXR)

  2010cites this paper
• Targetting farnesoid-X-receptor: from medicinal chemistry to disease treatment.

  2010cites this paper
• Deciphering the nuclear bile acid receptor FXR paradigm

  2010cites this paper
• Deciphering the nuclear bile acid receptor FXR

  2010cites this paper
• ANTI­HYPERLIPIDEMIC EFFECT OF TRIGLIZE, A POLYHERBAL FORMULATION

  2010cites this paper
• Moonlighting function of glycerol kinase causes systems-level changes in rat hepatoma cells.

  2010cites this paper
• Rational approaches to targeted polypharmacology: creating and navigating protein-ligand interaction networks.

  2010cites this paper
• Double-blind, placebo-controlled clinical evaluation of an Ayurvedic formulation (GlucoCare capsules) in non-insulin dependent diabetes mellitus

  2010cites this paper
• A Role of the Bile Salt Receptor FXR in Atherosclerosis

  2010cites this paper